Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jbt Marel (JBTM) Current Deferred Revenue (2016 - 2025)

Jbt Marel (JBTM) has 16 years of Current Deferred Revenue data on record, last reported at $498.5 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 180.06% year-over-year to $498.5 million; the TTM value through Dec 2025 reached $498.5 million, up 180.06%, while the annual FY2025 figure was $498.5 million, 180.06% up from the prior year.
  • Current Deferred Revenue reached $498.5 million in Q4 2025 per JBTM's latest filing, up from $482.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $508.0 million in Q2 2025 and bottomed at $132.9 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $215.4 million, with a median of $161.2 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: dropped 23.85% in 2024, then surged 264.94% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $156.5 million in 2021, then rose by 3.0% to $161.2 million in 2022, then decreased by 2.92% to $156.5 million in 2023, then grew by 13.74% to $178.0 million in 2024, then skyrocketed by 180.06% to $498.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $498.5 million in Q4 2025, $482.2 million in Q3 2025, and $508.0 million in Q2 2025.